Findings

What do systematic reviews say?

62 questions · 67 findings · 6 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 5 · 7.5%Very low 7 · 10.4%Low 26 · 38.8%Moderate 19 · 28.4%High 10 · 14.9%

Fixed‐dose combination aclidinium/formoterol vs aclidinium alone

Lung function · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD) 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 2333 participants
High

Fixed‐dose combination aclidinium/formoterol vs aclidinium alone

Adverse events (not including serious adverse events): number of participants · patients with chronic obstructive pulmonary disease

Fixed‐dose combination aclidinium/formoterol showed no clear difference in adverse events (not including serious adverse events): number of… compared with aclidinium alone (moderate certainty).

1 finding from 1 review

Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD) 2018 · Cochrane Headline outcomes only
OR 0.95 [0.76, 1.18]
3 studies · 2473 participants
Moderate